Home Tags Posts tagged with "Pharmaceutical Industry"

Tag: Pharmaceutical Industry

CCI closes case on anti-competitive pharmaceutical practices

Pharmaceutical manufacturers that voluntarily pay product information services (PIS) charges do not constitute a restrictive trade practice, the Competition Commission (CCI) of India says

Defendants fined INR1m for infringing Blue Cross pain mark

The Bombay High Court orders defendants to pay a INR1 million (USD10,501) fine for infringing Blue Cross Laboratories’ registered mark “Meftal-Spas”

Firms map out Sun Pharma’s USD11.75bn Organon acquisition

Firms guide Sun Pharmaceutical Industries, its subsidiaries and associate companies on the USD11.75 billion Organon acquisition

Unpacking China’s antitrust law regime

By Han Ye, Lushen Hong and Xiao Fu, Merits & Tree

China tightens antitrust rules with AML reforms and stricter enforcement

A comparison of developments in healthtech

South Korea boosts drug development; Russia tackles telemedicine and data protection

Healthcare update in South Korea

By Sung-Tae Kim, Hyun Wook Kim, Youngsik Byun and Minyoung Park, Shin & Kim

IHCF appoints new leader in Seoul

IHCF names Australian lawyer with 16 years in global pharma as new president

BJContinent achieves first reverse US takeover under new rules

Gibson Dunn, Orrick, and DeHeng facilitate BJContinent's historic reverse US takeover under new rule

How to amicably terminate a pharmaceutical BD project

By Aaron Gu and Zhu Min, Han Kun Law Offices

Addressing the need to centrally regulate pharma

By Abhai Pandey,Lex Orbis IP Practice

Correspondents

India Healthcare Investmentvideo

Healthcare investment in India: The PE playbook

By Ayush Jain, Bharucha & Partners
Philippine Citizenship By Marriage

Bride and prejudice: Gendered paths to Philippine citizenship

By Jewel M Culala, ACCRALAW
AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners

Follow us on LinkedIn

Follow now
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.